Hydrazonamides, hydroxypropaneamidines and secondary alcohols as potential antimalarial agents

Technology
Conceptual
University

Chemistry-driven synthesis of hydrazonamide, hydroxypropaneamidine, and secondary alcohol compounds designed as potential antimalarial drug candidates. This medicinal chemistry research explores novel molecular scaffolds for malaria treatment.

Overview

This research program focuses on the design and synthesis of three classes of compounds—hydrazonamides, hydroxypropaneamidines, and secondary alcohols—as potential antimalarial agents. Developed through a chemistry-driven synthesis approach, the work aims to identify novel molecular scaffolds that could contribute to the global effort against malaria. The research addresses the ongoing need for new antimalarial therapies, particularly in light of emerging drug resistance.

Technical specifications

Compound classes under investigation:

  • Hydrazonamides — nitrogen-containing molecular structures explored for biological activity against malaria parasites
  • Hydroxypropaneamidines — functionalized amidine derivatives designed for antimalarial potential
  • Secondary alcohols — hydroxyl-bearing compounds synthesized and evaluated as candidate antimalarial molecules

The approach is rooted in medicinal chemistry, employing targeted synthetic routes to generate and characterize these compound families for subsequent biological evaluation.

Technology readiness level

This research is at an early discovery stage. The compounds have been produced through chemistry-driven synthesis as a foundation for further biological testing and validation. Future validation steps will involve assessing antimalarial activity to determine which molecular scaffolds merit further development as drug candidates.


About Heinrich Heine Universität Düsseldorf

Heinrich Heine Universität Düsseldorf is a comprehensive public research university anchored by a major medical faculty and a modern science campus. An integrated university hospital and shared core facilities enable clinical translation and access to specialized instrumentation for joint studies. Companies collaborate through on‑campus spaces, contract research, and tailored partnership models, with quick reach to suppliers and manufacturing across North Rhine‑Westphalia’s Rhine‑Ruhr corridor. Research is supported by competitive funding from the German Research Foundation and federal and state ministries, alongside European Union programs. A dedicated technology transfer office manages IP, licensing, and startup support to accelerate industry uptake.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.